Search Results - "Felkins, Kathleen"
-
1
Cladribine transfer into human milk: A case report
Published in Multiple sclerosis (01-04-2021)“…Background: Cladribine is an antimetabolite used for the treatment of relapsing–remitting multiple sclerosis. At present, there are no data available on its…”
Get full text
Journal Article -
2
Pharmacokinetics of a single dose of oclacitinib maleate as a top dress in adult horses
Published in Journal of veterinary pharmacology and therapeutics (01-05-2022)“…The objective of this study was to determine the pharmacokinetic parameters of oclacitinib maleate as a top dress given to adult horses. Six adult horses with…”
Get full text
Journal Article -
3
Dimethyl fumarate transfer into human milk
Published in Therapeutic advances in neurological disorders (2020)“…Dimethyl fumarate (DMF) is approved for the treatment of relapsing-remitting multiple sclerosis. It is unknown whether DMF or its primary metabolite monomethyl…”
Get full text
Journal Article -
4
Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate “Natural” and “Inducible” CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer
Published in Cancer Immunology, Immunotherapy (01-06-2012)“…Adoptive T cell therapy for cancer patients optimally requires participation of CD4 T cells. In this phase I/II study, we assessed the therapeutic effects of…”
Get full text
Journal Article -
5
Human Milk Endocannabinoid Levels as a Function of Obesity and Diurnal Rhythm
Published in Nutrients (01-07-2021)“…The endocannabinoid system is involved in the regulation of a variety of physiological and cognitive processes. While the endocannabinoids…”
Get full text
Journal Article -
6
Cytotoxic T-lymphocyte Immunotherapy for Ovarian Cancer: A Pilot Study
Published in Journal of immunotherapy (1997) (01-02-2012)“…The objective was to evaluate the toxicity and feasibility of intraperitoneal infusion of tumor-specific cytotoxic T lymphocytes (CTL) as therapy for recurrent…”
Get full text
Journal Article -
7
CD8-Mediated Type 1 Antitumor Responses Selectively Modulate Endogenous Differentiated and Nondifferentiated T Cell Localization, Activation, and Function in Progressive Breast Cancer
Published in Journal of Immunology (01-12-2006)“…CD8 T cell-mediated immune responses fall into two distinct types based on effector cell-derived cytokine production. Type I CD8 T cells (Tc1) produce…”
Get full text
Journal Article -
8
Costimulation with anti-cluster of differentiation 3 and anti-cluster of differentiation 28 reduces the activity of mucin 1-stimulated human mononuclear cells
Published in Oncology letters (01-01-2016)“…Cytotoxic T-lymphocyte activation and extension of the cell life span is necessary in order to enable immunotherapy to perform effectively against cancer. In…”
Get full text
Journal Article -
9
Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival
Published in Clinical immunology (Orlando, Fla.) (01-12-2009)“…Abstract Adoptive T cell immunotherapy using autologous lymphocytes is a viable treatment for patients with cancer and requires participation of Ag-specific…”
Get full text
Journal Article -
10
Targeting Migration inducting gene-7 inhibits carcinoma cell invasion, early primary tumor growth, and stimulates monocyte oncolytic activity
Published in Molecular cancer therapeutics (01-08-2009)“…Expression of Migration inducting gene-7 (Mig-7) is limited to tumor cells and to date not found in normal tissues. Multiple tumor microenvironment factors,…”
Get full text
Journal Article -
11
Dendritic cells enhance the activity of human MUC1-stimulated mononuclear cells against breast cancer
Published in Oncoimmunology (01-02-2013)“…Dendritic cells (DCs) are among the most potent antigen-presenting cells (APCs), stimulating peripheral blood mononuclear cells (PBMCs) to generate…”
Get full text
Journal Article -
12
Tucaresol down-modulation of MUC1-stimulated human mononuclear cells
Published in Immunological investigations (01-01-2014)“…Interaction between antigen presenting cells and T lymphocytes, through receptors and co-stimulatory molecules present on the surface of these cells, is one of…”
Get full text
Journal Article -
13
TGFα-PE38 enhances cytotoxic T-lymphocyte killing of breast cancer cells
Published in Oncology letters (01-06-2014)“…The aim of the present study was to determine whether the combination of two modalities of immunotherapy, targeting two different tumor antigens, may be…”
Get full text
Journal Article -
14
Prevention of human adenocarcinoma with CpG-ODN in a mouse model
Published in Oncology letters (01-11-2012)“…CpG-ODNs activate various immune cell subsets and induce the production of numerous cytokines. To determine whether a CpG-ODN-activated innate immune system,…”
Get full text
Journal Article -
15
Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating differentiated T cell localization, activation and chemokine production in established breast cancer
Published in Clinical immunology (Orlando, Fla.) (01-08-2008)“…Abstract The chemotherapeutic agent methotrexate is widely used in the treatment of breast cancer. Although its mechanism-of-action has been defined, less is…”
Get full text
Journal Article -
16
Tumor Burden Influences Cytotoxic T Cell Development in Metastatic Breast Cancer Patients-A Phase I II Study
Published in Immunological investigations (01-11-2009)“…The influence of tumor burden on the generation of tumor antigen-specific cytotoxic T-lymphocytes (CTL) was investigated in a phase I II clinical adoptive…”
Get full text
Journal Article -
17
MHC-Unrestricted Lysis of MUC1-Expressing Cells by Human Peripheral Blood Mononuclear Cells
Published in Immunological investigations (01-01-2008)“…Many human adenocarcinomas can be killed in vitro by targeted cytotoxic T-lymphocytes (CTL); however, major histocompatibility complex (MHC)-restrictions are…”
Get full text
Journal Article -
18
Number of Treatment Cycles Influences Development of Cytotoxic T Cells in Metastatic Breast Cancer Patients - A Phase I II Study
Published in Immunological investigations (2010)“…The influence of the number of apheresis-stimulation-infusion(s) cycles, and the time in culture before the infusion (one vs. two weeks), on the generation of…”
Get full text
Journal Article -
19
Ag-Specific Type 1 CD8 Effector Cells Enhance Methotrexate-Mediated Antitumor Responses by Modulating Endogenous CD49b-Expressing CD4 and CD8 T Effector Cell Subpopulations Producing IL-10
Published in Immunological investigations (01-01-2008)“…The chemotherapeutic agent methotrexate is widely used in the treatment of breast cancer. Although its mechanism-of-action has been defined, less is known…”
Get full text
Journal Article -
20
Transfer of Inhaled Cannabis Into Human Breast Milk
Published in Obstetrics and gynecology (New York. 1953) (01-05-2018)“…OBJECTIVE:To evaluate the transfer of delta-9-tetrahydrocannabinol and its metabolites into human breast milk after maternal inhalation of 0.1 g cannabis…”
Get full text
Journal Article